We are live on ! Find out more
WCMN

Westchester Capital Management (Nebraska) Portfolio holdings

AUM $555M
1-Year Est. Return 50.73%
This Fund
S&P 500
This Quarter Est. Return
+13.77%
1 Year Est. Return
+50.73%
3 Year Est. Return
+107.07%
5 Year Est. Return
+146.12%
10 Year Est. Return
+436.97%
AUM
$317M
AUM Growth
+$35M
Cap. Flow
+$228K
Cap. Flow %
0.07%
Top 10 Hldgs %
48.74%
Holding
56
New
12
Increased
9
Reduced
23
Closed
1

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$414K
2
AAPL icon
Apple
AAPL
+$353K
3
XOM icon
ExxonMobil
XOM
+$270K
4
CAT icon
Caterpillar
CAT
+$243K
5
MSFT icon
Microsoft
MSFT
+$185K

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 23.61%
3 Industrials 13.25%
4 Financials 10.91%
5 Communication Services 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMN icon
51
Lumen
LUMN
$6.58B
$1K ﹤0.01%
75
SOHU
52
Sohu.com
SOHU
$371M
$1K ﹤0.01%
+50
New +$917
ZUO
53
DELISTED
Zuora, Inc.
ZUO
$1K ﹤0.01%
+100
New +$1.14K
NOG icon
54
Northern Oil and Gas
NOG
$2.58B
$0 ﹤0.01%
+20
New +$124
SYF icon
55
Synchrony
SYF
$25.5B
-2,225
Closed -$58K
WAB icon
56
Wabtec
WAB
$50.3B
$0 ﹤0.01%
1

Similar funds

Westchester Capital Management (Nebraska)'s Q4 2020 Portfolio in Review

As of Q4 2020, Westchester Capital Management (Nebraska) held 56 positions worth $317M, up 12% from $282M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Westchester Capital Management (Nebraska)'s Q4 2020 filing shows 12 new, 9 increased, 23 reduced and 1 closed positions. Its largest new stake was Viatris: 34,088 shares worth $639K. The largest sale was Pfizer, an estimated $414K.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Westchester Capital Management (Nebraska)'s largest Q4 2020 buy was Viatris: 34,088 shares worth $639K.
  • Westchester Capital Management (Nebraska) added most to Vanguard Short-Term Treasury ETF in Q4 2020, an estimated $350K increase.
  • Westchester Capital Management (Nebraska)'s biggest Q4 2020 reduction was Pfizer, cutting an estimated $414K.
  • Westchester Capital Management (Nebraska) fully exited Synchrony in Q4 2020, selling an estimated $58K.
  • Westchester Capital Management (Nebraska)'s ten largest holdings make up 49% of its $317M portfolio in Q4 2020.
  • Westchester Capital Management (Nebraska) opened 12 new positions and closed 1 in Q4 2020.
  • Westchester Capital Management (Nebraska)'s portfolio value rose 12% quarter-over-quarter to $317M.

Based on Westchester Capital Management (Nebraska)'s 13F filing for Q4 2020, filed 8 Feb 2021.